LifeMD Reschedules Third Quarter 2026 Earnings Release and Conference Call to November 12, 2026
LifeMD (Nasdaq: LFMD) has rescheduled its third quarter 2026 earnings release and conference call to November 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LifeMD (Nasdaq: LFMD) has rescheduled its third quarter 2026 earnings release and conference call to November 12, 2026.
The company expects to issue its earnings release at approximately 4:05 p.m. Eastern time, followed by the conference call at 4:30 p.m. Eastern time. A live and archived webcast will be available.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that the Company has rescheduled its third quarter 2026 earnings release and conference call to Thursday, November 12, 2026.
LifeMD expects to issue its third quarter 2026 earnings press release on or around 4:05 p.m. Eastern time on Thursday, November 12, 2026 followed by the conference call at 4:30 p.m. Eastern time. Information for the rescheduled conference call is as follows:
Conference Call & Webcast Details
| Date: | Thursday, November 12th |
| Time: | 4:30 p.m. Eastern time |
| Toll-Free Dial-In: | (877) 270-2148 |
| International Dial-In: | +1 (412) 902-6510 |
| Conference ID: | LifeMD, Inc. Third Quarter 2026 Results |
| Live & Archived Webcast: | Link |
About LifeMD, Inc.
LifeMD® is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art nationwide pharmacy with home delivery, and a U.S.-based patient care center. Together, these capabilities support care across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. For more information, please visit LifeMD.com.
Investor Contact
ir@lifemd.com
Media Contact
press@lifemd.com
